Metropolitan Life Insurance Company (MetLife)’s Chemed CHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-2,933
| Closed | -$1.55M | – | 2325 |
|
|
2021
Q4 | $1.55M | Sell |
2,933
-124
| -4% | -$59.5K | 0.02% | 675 |
|
|
2021
Q3 | $1.42M | Sell |
3,057
-150
| -5% | -$70.7K | 0.02% | 715 |
|
|
2021
Q2 | $1.52M | Sell |
3,207
-628
| -16% | -$302K | 0.02% | 701 |
|
|
2021
Q1 | $1.76M | Buy |
3,835
+108
| +3% | +$52.9K | 0.03% | 579 |
|
|
2020
Q4 | $1.99M | Sell |
3,727
-85
| -2% | -$41.8K | 0.03% | 476 |
|
|
2020
Q3 | $1.83M | Sell |
3,812
-174
| -4% | -$85.3K | 0.03% | 450 |
|
|
2020
Q2 | $1.8M | Sell |
3,986
-980
| -20% | -$438K | 0.03% | 441 |
|
|
2020
Q1 | $2.15M | Sell |
4,966
-266
| -5% | -$119K | 0.04% | 353 |
|
|
2019
Q4 | $2.3M | Buy |
5,232
+27
| +0.5% | +$11.4K | 0.04% | 468 |
|
|
2019
Q3 | $2.17M | Sell |
5,205
-109
| -2% | -$44.5K | 0.04% | 466 |
|
|
2019
Q2 | $1.92M | Sell |
5,314
-32
| -0.6% | -$10.7K | 0.03% | 545 |
|
|
2019
Q1 | $1.71M | Sell |
5,346
-38
| -0.7% | -$11.7K | 0.03% | 569 |
|
|
2018
Q4 | $1.53M | Sell |
5,384
-13
| -0.2% | -$3.92K | 0.03% | 570 |
|
|
2018
Q3 | $1.72M | Buy |
5,397
+7
| +0.1% | +$2.23K | 0.03% | 602 |
|
|
2018
Q2 | $1.73M | Buy |
5,390
+503
| +10% | +$157K | 0.03% | 599 |
|
|
2018
Q1 | $1.33M | Sell |
4,887
-83
| -2% | -$22K | 0.02% | 755 |
|
|
2017
Q4 | $1.21M | Buy |
+4,970
| New | +$1.13M | 0.02% | 805 |
|
|
2017
Q3 | – | Sell |
-11,116
| Closed | -$2.27M | – | 2470 |
|
|
2017
Q2 | $2.27M | Sell |
11,116
-100
| -0.9% | -$19.9K | 0.02% | 910 |
|
|
2017
Q1 | $2.05M | Sell |
11,216
-248
| -2% | -$43.2K | 0.01% | 945 |
|
|
2016
Q4 | $1.84M | Sell |
11,464
-242
| -2% | -$35.5K | 0.01% | 1006 |
|
|
2016
Q3 | $1.65M | Sell |
11,706
-827
| -7% | -$115K | 0.01% | 1025 |
|
|
2016
Q2 | $1.71M | Hold |
12,533
| – | – | 0.01% | 1001 |
|
|
2016
Q1 | $1.7M | Buy |
12,533
+553
| +5% | +$74.7K | 0.01% | 948 |
|
|
2015
Q4 | $1.79M | Hold |
11,980
| – | – | 0.01% | 934 |
|
|
2015
Q3 | $1.6M | Buy |
11,980
+99
| +0.8% | +$13.9K | 0.01% | 1001 |
|
|
2015
Q2 | $1.56M | Sell |
11,881
-1,308
| -10% | -$162K | 0.01% | 1061 |
|
|
2015
Q1 | $1.57M | Sell |
13,189
-90
| -0.7% | -$9.99K | 0.01% | 978 |
|
|
2014
Q4 | $1.4M | Hold |
13,279
| – | – | 0.01% | 1126 |
|
|
2014
Q3 | $1.37M | Sell |
13,279
-879
| -6% | -$89.1K | 0.01% | 1100 |
|
|
2014
Q2 | $1.33M | Hold |
14,158
| – | – | 0.01% | 1177 |
|
|
2014
Q1 | $1.27M | Sell |
14,158
-123
| -0.9% | -$10K | 0.01% | 1191 |
|
|
2013
Q4 | $1.09M | Sell |
14,281
-641
| -4% | -$47.3K | 0.01% | 1267 |
|
|
2013
Q3 | $1.07M | Hold |
14,922
| – | – | 0.01% | 1241 |
|
|
2013
Q2 | $1.08M | Buy |
+14,922
| New | +$1.09M | 0.01% | 1185 |
|
Other funds holding CHE
Metropolitan Life Insurance Company (MetLife)'s CHE Position: Q1 2022 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Chemed (CHE) in Q1 2022, closing a stake of 2,933 shares — an estimated $1.55M sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in CHE in Q2 2013 and held it in 34 quarters. The position peaked at $2.3M in Q4 2019. 426 funds tracked by Wall St. Rank hold CHE as of Q1 2022.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Chemed position as of Q1 2022 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 2,933 Chemed shares in Q1 2022, an estimated $1.55M.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Chemed in Q2 2013 and held it in 34 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Chemed position peaked at $2.3M in Q4 2019.
- 426 funds tracked by Wall St. Rank held Chemed as of Q1 2022.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.